• STAT Plus: Pharmalittle: Gilead to pay $21 billion to buy Immunomedics; Trump releases executive order on drug pricing

    5 days ago - By STAT

    Good morning, everyone, and welcome to another working week. We hope the weekend respite was somehow relaxing and invigorating, because the predictable routine of Zoom calls, phone calls, and deadlines has assuredly returned. Despite the sometimes overwhelming events of the moment, the world keeps spinning. So what can you do but fire up the coffee kettle and enjoy a cup of needed stimulation? Once again, we are downing maple bourbon. Meanwhile, here are a few tidbits to help you get started. Hope all goes well, and do stay in touch....
    Gilead Sciences will pay $21 billion to buy...
    Read more ...

     

  • STAT Plus: Inside Gilead's $21 billion purchase of Immunomedics: Lamb chops, steak, and a chance for transformation

    5 days ago - By STAT

    Key negotiations that helped seal Gilead Science's $21 billion purchase of Immunomedics, announced Sunday, took place on the makeshift patio of a suburban New Jersey restaurant during a socially distanced dinner two weeks ago, separated from a highway by some hedges.
    Immunomedics' Executive Chairman Behzad Aghazadeh, eating at a restaurant for the first time since the Covid-19 pandemic struck, ordered lamb chops. Gilead CEO Daniel O'Day had steak. They requested a table away from other diners in order to be discrete. But the main thing on the menu, from Gilead's perspective, was Trodelvy...
    Read more ...